Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2

BACKGROUND: Hexokinase (HK) is the rate-limiting enzyme in the first reaction of glycolysis. And Hexokinase 2 (HK2) is most closely related to malignant tumor which expresses at higher level compared with normal cells. HK2 plays a pivotal role in tumor initiation and maintenance, which provides a ne...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Li, Wei, Zheng, Mengzhu, Wu, Shuangping, Gao, Suyu, Yang, Mei, Li, Zhimei, Min, Qiuxia, Sun, Weiguang, Chen, Lixia, Xiang, Guangya, Li, Hua
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399312/
https://ncbi.nlm.nih.gov/pubmed/28427443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0530-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados